These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5467696)

  • 21. [Plastic covering for corticosteroid salves in psoriasis. Therapeutic trials with fluocinolone acetonide, triamcinolone acetonide and dichlorisone acetate].
    WEREIDE K
    Tidsskr Nor Laegeforen; 1963 Jun; 83():1034-7. PubMed ID: 13999986
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids.
    Evans DP; Hossack M; Thomson DS
    Br J Pharmacol; 1971 Oct; 43(2):403-8. PubMed ID: 5158205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts.
    Haeck IM; Rouwen TJ; Timmer-de Mik L; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2011 Feb; 64(2):275-81. PubMed ID: 21122943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Local effect of corticosteroids].
    Koźmińska A
    Przegl Dermatol; 1969; 56(4):505-10. PubMed ID: 4902946
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects and side effects of corticosteroids in allotransplantation].
    Klaue P
    Fortschr Med; 1976 Mar; 94(9):491-500. PubMed ID: 786840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CLINICAL TRIALS WITH TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS. PRELIMINARY REPORT.
    KATONA G; ROBLESGIL J
    Arch Interam Rheumatol; 1964 Mar; 7():93-103. PubMed ID: 14154187
    [No Abstract]   [Full Text] [Related]  

  • 27. Corticosteroids and adrenal function.
    JAMA; 1969 Sep; 209(11):1713. PubMed ID: 5820170
    [No Abstract]   [Full Text] [Related]  

  • 28. A prospective observational study to compare efficacy of topical triamcinolone acetonide 0.1% oral paste, oral methotrexate, and a combination of topical triamcinolone acetonide 0.1% and oral methotrexate in moderate to severe oral lichen planus.
    Chauhan P; De D; Handa S; Narang T; Saikia UN
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29124831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonide.
    Zacharias LC; Lin T; Migon R; Ghosn C; Orilla W; Feldmann B; Ruiz G; Li Y; Burke J; Kuppermann BD
    Retina; 2013 Mar; 33(3):522-31. PubMed ID: 22990317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extemporaneous dilutions of proprietary topical corticosteroid preparations.
    Kirsch JM; Gibson JR; Darley C; Barrett CW
    Dermatologica; 1982 Jul; 165(1):71-2. PubMed ID: 7117653
    [No Abstract]   [Full Text] [Related]  

  • 31. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids].
    Koch EM; Ott R; Koehler CO
    Arzneimittelforschung; 1986 Oct; 36(10):1540-4. PubMed ID: 3814215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial.
    Bodick N; Lufkin J; Willwerth C; Kumar A; Bolognese J; Schoonmaker C; Ballal R; Hunter D; Clayman M
    J Bone Joint Surg Am; 2015 Jun; 97(11):877-88. PubMed ID: 26041848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Withdrawal of corticosteroids.
    Arnold HL
    Lancet; 1976 Jan; 1(7951):149. PubMed ID: 54664
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonide-loaded hydrogel prepared using an electron beam.
    Choi SG; Baek EJ; Davaa E; Nho YC; Lim YM; Park JS; Gwon HJ; Huh KM; Park JS
    Int J Pharm; 2013 Apr; 447(1-2):102-8. PubMed ID: 23467084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Granulomatous lung diseases and their treatment with corticosteroids].
    Goldman S
    Pneumonol Pol; 1976; 44(4):325-31. PubMed ID: 1264823
    [No Abstract]   [Full Text] [Related]  

  • 36. The use of corticosteroids in the treatment of asthma.
    Spector SL
    Chest; 1985 Jan; 87(1 Suppl):73S-79S. PubMed ID: 3880534
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders.
    Pradhan M; Singh D; Singh MR
    Artif Cells Nanomed Biotechnol; 2016; 44(1):392-400. PubMed ID: 25229831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postmenopausal bleeding and corticosteroids.
    Klomp HA; van der Linden PJ
    Gynecol Obstet Invest; 2013; 76(4):260. PubMed ID: 23735996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.